President Trump Just Reclassified Marijuana. Are Green Thumb, Tilray, and Trulieve Stocks No-Brainer Buys?

Core Viewpoint - The reclassification of marijuana from Schedule I to Schedule III by President Trump on December 18, 2025, represents a significant shift in federal cannabis policy, acknowledging its medical uses and impacting the cannabis industry positively [1][3]. Industry Implications - The executive order allows cannabis companies to deduct more business expenses, which was previously restricted under IRS Code Section 280E, benefiting companies like Green Thumb Industries, Tilray Brands, and Trulieve Cannabis [5][6]. - The reclassification reflects the reality that 40 U.S. states, three territories, and the District of Columbia have legalized medical cannabis, indicating a broader acceptance of marijuana's medical applications [3]. Company Impact - Green Thumb, Tilray, and Trulieve have expressed support for the reclassification, which is expected to provide them with financial advantages and operational flexibility [4][5]. - The exemption from IRS Code Section 280E is particularly critical, as it allows these companies to deduct expenses related to payroll and rent, which were previously non-deductible [6].